NAUT

NASDAQStock

Nautilus Biotechnology, Inc.

$2.35+0.07 (+2.84%)

52-Week Range

$0.64
$2.89

Key Stats

Market Cap

297.4M

P/E Ratio

Dividend Yield

Beta

1.36

Volume

122.3K

Avg Volume

205.2K

Performance

1M

+7.51%

3M

+20.53%

6M

+195.71%

YTD

+19.90%

1Y

+106.31%

3Y

+3.62%

5Y

-79.18%

Price Chart

ETF Exposure

NAUT is held by 11 ETFs

ETFFund NameWeight
DFASDimensional - US Small Cap ETF0.00%
VXFVanguard Extended Market ETF0.00%
AVSCAvantis U.S. Small Cap Equity ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
DFACDimensional - US Core Equity 2 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%

About NAUT ETF Exposure

Nautilus Biotechnology, Inc. (NAUT) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 297.4M, NAUT is a widely held institutional stock. The stock currently trades at $2.35. Investors can gain exposure to NAUT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NAUT, sorted by portfolio weight.